Conatus Pharmaceuticals Analysis
Conatus Pharmaceuticals is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Conatus Pharmaceuticals delisted stock analysis is to determine its intrinsic value, which is an estimate of what Conatus Pharmaceuticals is worth, separate from its market price. There are two main types of Conatus Pharmaceuticals' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Conatus Pharmaceuticals' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Conatus Pharmaceuticals' stock to identify patterns and trends that may indicate its future price movements.
The Conatus Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Conatus Pharmaceuticals is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Conatus Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Conatus Pharmaceuticals' ongoing operational relationships across important fundamental and technical indicators.
Conatus |
Conatus Stock Analysis Notes
About 14.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.66. Some equities with similar Price to Book (P/B) outperform the market in the long run. Conatus Pharmaceuticals recorded a loss per share of 0.39. The entity had not issued any dividends in recent years. Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines for the treatment of liver diseases in the United States. Conatus Pharmaceuticals Inc. was founded in 2005 and is headquartered in San Diego, California. Conatus Pharmaceuticals operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 5 people. For more info on Conatus Pharmaceuticals please contact Steven Mento at 858 376-2600 or go to www.conatuspharma.com.Conatus Pharmaceuticals Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Conatus Pharmaceuticals' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Conatus Pharmaceuticals or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Conatus Pharmaceuticals is not yet fully synchronised with the market data | |
| Conatus Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Conatus Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 28.6 M. Net Loss for the year was (12.56 M) with loss before overhead, payroll, taxes, and interest of (1.81 M). | |
| Conatus Pharmaceuticals currently holds about 22.68 M in cash with (27.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of -1.1166. |
Conatus Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 18.44 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Conatus Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Conatus Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Conatus Profitablity
Conatus Pharmaceuticals' profitability indicators refer to fundamental financial ratios that showcase Conatus Pharmaceuticals' ability to generate income relative to its revenue or operating costs. If, let's say, Conatus Pharmaceuticals is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Conatus Pharmaceuticals' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Conatus Pharmaceuticals' profitability requires more research than a typical breakdown of Conatus Pharmaceuticals' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.57) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (46.04) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $46.04.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Conatus Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Conatus Pharmaceuticals information on this page should be used as a complementary analysis to other Conatus Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in Conatus Stock
If you are still planning to invest in Conatus Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Conatus Pharmaceuticals' history and understand the potential risks before investing.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |